Intrathecal cholinergic agonists lessen bupivacaine spinal-block-induced hypotension in rats.

Hypotension is an important side effect of spinal anesthesia. Intrathecal (IT) cholinergic agonists, including neostigmine (NEO), increase arterial blood pressure by stimulating spinal sympathetic neurons. Therefore, we tested the ability of IT cholinergic agonists to prevent the hypotensive effect of IT bupivacaine (BUP) (430 nmol) in rats instrumented with IT and arterial catheters. The mean arterial pressure (MAP) decreased 35 +/- 4 mm Hg (n = 10) after IT-BUP alone. In contrast, MAP did not significantly change after IT-BUP + IT-NEO (12.5 and 25 nmol; n = 5 for each dose). Intramuscular (IM) NEO was not effective, and MAP decreased 38 +/- 4 mm Hg after IT-BUP + IM-NEO (25 nmol; n = 5). Three additional cholinesterase inhibitors, physostigmine, edrophonium, and ambenonium, as well as the direct-acting cholinergic agonists carbachol, oxotremorine, and arecoline, each lessened the hypotension seen after IT-BUP. Furthermore, the nonselective muscarinic antagonist, atropine, as well as the M2 receptor selective antagonist, methoctramine, prevented the vasopressor effect of IT-NEO in our model. Finally, the nicotinic antagonist, mecamylamine, and the M1 selective antagonist, pirenzepine, did not affect the pressor effects of NEO in our model. In conclusion, IT cholinergic agonists lessen BUP spinal-block-induced hypotension in rats by a muscarinic dependent pathway.

[1]  D. Wedel.  Physiology of Spinal Anesthesia, 4th ed. , 1994 .

[2]  J. Eisenach,et al.  Spinal Clonidine Hypotension: Mechanism of Reversal by Spinal Neostigmine , 1993, Regional Anesthesia & Pain Medicine.

[3]  J. Eisenach,et al.  Neostigmine Counteracts Spinal Clonidine‐induced Hypotension in Sheep , 1993, Anesthesiology.

[4]  T. Yaksh,et al.  Interaction of intrathecal morphine with bupivacaine and lidocaine in the rat. , 1992, Anesthesiology.

[5]  J. Buccafusco,et al.  The sympathoexcitatory response following selective activation of a spinal cholinergic system in anesthetized rats. , 1991, Journal of the autonomic nervous system.

[6]  F. Calaresu,et al.  Microinjection of substance P and ACh into rat intermediolateral nucleus elicits cardiovascular responses. , 1990, The American journal of physiology.

[7]  J. Buccafusco,et al.  Hypertension following intrathecal injection of cholinergic agonists in conscious rats: role of endogenous acetylcholine. , 1988, Journal of the autonomic nervous system.

[8]  A. Krieger,et al.  M2 muscarinic receptors mediate pressor responses to cholinergic agonists in the ventrolateral medullary pressor area , 1988, Brain Research.

[9]  C. Melchiorre,et al.  Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine. , 1988, The Journal of pharmacology and experimental therapeutics.

[10]  E. Albuquerque,et al.  The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist. , 1985, Molecular pharmacology.

[11]  R. Elde,et al.  Receptor autoradiography in thoracic spinal cord: correlation of neurotransmitter binding sites with sympathoadrenal neurons , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  A. Atkinson,et al.  The pharmacological basis of therapeutics. 6th ed: By Alfred Goodman Gilman, Louis S. Goodman, and Alfred Gilman. 1843 pp., $45.00. Macmillan Publishing Co., Inc., New York, New York, 1980 , 1981 .

[13]  J. Nutt,et al.  Treatment of Huntington disease with a cholinergic agonist , 1978, Neurology.

[14]  T. Yaksh,et al.  Chronic catheterization of the spinal subarachnoid space , 1976, Physiology & Behavior.

[15]  M. Harmel,et al.  Physiology of Spinal Anesthesia , 1970, The Yale Journal of Biology and Medicine.

[16]  M. Kremer.  ACTION OF INTRATHECALLY INJECTED PROSTIGMINE, ACETYLCHOLINE, AND ESERINE ON THE CENTRAL NERVOUS SYSTEM IN MAN , 1942 .

[17]  J. Eisenach,et al.  Site of hemodynamic effects of intrathecal alpha 2-adrenergic agonists. , 1991, Anesthesiology.

[18]  F. Mitchelson,et al.  Muscarinic receptor differentiation. , 1988, Pharmacology & therapeutics.

[19]  T. Yaksh,et al.  Studies in animals should precede human use of spinally administered drugs. , 1989, Anesthesiology.

[20]  H. Brezenoff,et al.  Cardiovascular control by cholinergic mechanisms in the central nervous system. , 1982, Annual review of pharmacology and toxicology.

[21]  A. Karczmar,et al.  Anticholinesterase Agents. , 1963, Science.